Introducing i.Mune™ Tests*

i.Mune™ TBNK*

Relative and absolute quantification** of CD3+/CD4+/CD8+ T-, B- and NK lymphocytes from dried blood spots (DBS) or fresh blood

i.Mune™ NEO* (in development)

Relative quantification** of CD3+ T-, B- and NK lymphocytes, TSDR+ regulatory T cells (Treg) and neutrophils from dried blood spots (DBS).


(TSDR = Treg Specific De-methylated Region)

i.Mune™ PID* (in development)

Relative and absolute quantification** of CD3+/CD4+/CD8+ T-, B-, NK cells, Treg, neutrophils and monocytes from dried blood spots (DBS) or fresh blood

*i.Mune™ tests are for research use, only and have not been registered as IVD products and have not been approved or cleared by a regulatory authority.

**Relative quantification (%) is possible for all sample types; absolute quantification (cells/µl) currently for fresh blood, only


Epimune™ and i.Mune™ are registered trademarks of Epimune GmbH, in Europe, USA and/or other selected countries, with trademarks pending in the US. All other trademarks, brands, names contained herein are the property of their respective owners.